Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

Keros’ elritercept has shown promising efficacy signals in myelofibrosis and myelodysplastic syndromes and could pose a ...

Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...

Takeda ( TSE:4502/NYSE:TAK ) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, Inc. (Nasdaq: KROS) to further develop, manufacture and commercialize ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

Spinach has iron, calcium, and phosphorus, micronutrients essential to a well-rounded diet. Learn how many milligrams of iron ...

A breath of pressurized, oxygen-rich air can change the lives of patients with PTSD and many other conditions.

The following is a summary of “Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...

Treatment involves addressing the underlying deficiency through dietary changes, supplementation, or medical interventions, aiming to restore normal red blood cell production and alleviate symptoms of ...

While anemia impacts nearly a quarter of the world's population ... specifically when factoring in the under-detected ...

The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.